Table 2.

Baseline characteristics.

	Treatment group (n = 6)	Control group (n = 6)	p value
Sex, n (%) male/female	4 (67%)/2 (33%)	2 (33%)/4 (67%)	0.6
Age in years, mean ± SD	60 ± 11	61 ± 9	0.9
Month post stroke, mean ± SD	62 ± 43	51 ± 33	0.6
Type of stroke, n (%) ischemic/hemorrhagic	5 (83%)/1 (17%)	4 (67%)/2 (33%)	1.0
Upper extremity Fugl-Meyer, mean ± SD	49 ± 13	48 ± 10	0.9
Box and block test score, mean ± SD	36 ± 17	29 ± 17	0.5
Self-efficacy score, mean ± SD	3.3 ± 0.4	3.3 ± 0.3	1.0